Insulin-like growth factors

Growth Factors and Cytokines in Health and Disease

Volumn 1, Issue C, 1996, Pages 1-26

  LeRoith, Derek ^a   Bondy, Carolyn ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0343090698     PISSN: 18745687     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1874-5687(96)80003-6     Document Type: Review

References (158)

1. Abbott A.M., Bueno R., Pedrini M.T., Murray J.M., and Smith R.J. Insulin-like growth factor I receptor gene structure. J. Biol. Chem. 267 (1992) 10759-10763
2. Arai T., Aria A., Busby Jr. W.H., and Clemmons D.R. Glycosaminoglycans inhibit degradation of insulin-like growth factor-binding protein-5. Endocrinology 135 (1994) 2358-2363
3. Arai T., Parker A., Busby Jr. W.H., and Clemmons D.R. Heparin, heparin sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor I and insulin-like growth factor-binding protein complexes. J. Biol. Chem. 269 (1994) 20366-20393
4. Bach M.A., Chin E., and Bondy C.A. The effects of recombinant insulin-like growth factor I (IGF-I) on growth hormone, IGF-II, IGF binding protein and blood glucose levels in normal and diabetic adolescents. J. C. E. M. 79 (1994) 1040-1046
5. Baker J., Liu J.-P., Robertson E.J., and Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75 (1993) 73-82
6. Baltensperger K., Kozma L.M., Cherniak A.D., Klarlund J.K., Chawla A., Banerjee U., and Czech M.P. Binding of the ras activator son of sevenless to insulin receptor substrate-1 signaling complexes. Science 260 (1993) 1950-1952
7. Bar R.S., Booth B.A., Bowes M., and Drake B.L. Insulin-like growth factor binding proteins from cultured endothelial cells: Purification, characterization, and intrinsic biologic activities. Endocrinology 125 (1989) 1910-1920
8. Bar R.S., Bowes M., Clemmons D.R., Busby W.H., Sandra A., Drake B.L., and Booth B.A. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF binding proteins in rat heart. Endocrinology 127 (1990) 497-499
9. Baserga R. The insulin-like growth factor I receptor: A key to tumor growth?. Cancer Res. 55 (1995) 249-252
10. Baxter R.C., and Martin J.L. Binding proteins for insulin-like growth factors: Structure, regulation, and function. Prog. Growth Fact. Res. 1 (1989) 49-69
11. Baxter R.C., and Martin J.L. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: Determination by reconstitution and affinity labeling. Proc. Natl. Acad. Sci. USA 86 (1989) 6898-6902
12. Beitner-Johnson D., and LeRoith D. Insulin-like growth factor I stimulates tyrosine phosphorylation of endogenous c-Crk. J. Biol. Chem. 270 (1995) 5187-5190
13. Bierich F.R., Moeller H., Ranke M.B., and Rosenfeld R.G. Pseudopituitary dwarfism due to resistance to somatomedin: A new syndrome. Eur. J. Pediatr. 142 (1984) 186-188
14. Blum W.F., Jenne E.W., Reppin F., Kietzmann K., Ranke M.B., and Bierich J.R. Insulin-like growth factor I (IGF-I) binding protein complex is a better mitogen than free IGF-I. Endocrinology 125 (1989) 766-772
15. Blundell T.L., Bedarkar S., and Humbel R.E. Tertiary structures, receptor binding, and antigenicity of insulin-like growth factors. Fed. Proc. 42 (1983) 2592-2597
16. Bolinder J., Lindblad A., Engfeldt P., and Arner P. Studies of acute effects of insulin-like growth factors I and II in human fat cells. J. Clin. Endocrinol. Metab. 65 (1987) 732-737
17. Bondy C.A., Underwood L., Clemmons D.R., Guler H.P., Bach M.A., and Skarulls M.C. Clinical uses of insulin-like growth factor I. Ann. Int. Med. 120 (1994) 593-601
18. Bondy C.A., Werner H., Roberts C., and LeRoith D. Cellular pattern of insulin-like growth factor I and type I IGF receptor gene expression in early organogenesis; comparison with IGF-II gene expression. Mol. Endocrinol. 4 (1990) 1386-1398
19. Bouillon R. Growth hormone and bone. Hormone Res. 36 (1991) 49-55
20. Boulware S.D., Tamborlane W.V., Matthews L.S., and Sherwin R.S. Diverse effects of insulin-like growth factor I on glucose, lipid, and amino acid metabolism. Am. J. Physiol. 262 (1992) E130-E133
21. Camacho-Hubner C., Busby Jr. W.H., McCusker R.H., Wright G., and Clemmons D.R. Identification of the forms of insulin-like growth factor binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J. Biol. Chem. 267 (1992) 11949-11956
22. Cascieri M.A., Chicchi G.G., Hayes N.S., and Strader C.D. (Thr-59)-insulin-like growth factor I stimulates 2-deoxyglucose transport in BC3H1 myocytes through the insulin-like growth factor receptor, not the insulin receptor. Biochem. Biophys. Acta. 886 (1986) 491-499
23. Cheetham T.D., Jones J., Taylor A.T., Holly J., Matthews D.R., and Dunger D.B. The effects of IGF-I administration on growth hormone levels and insulin requirements in adolescents with type 1 (insulin-dependent) diabetes mellitus. Diabetologica 36 (1993) 678-681
24. Christofori G., Naik P., and Hanahan D. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369 (1994) 414-417
25. Clemmons D.R., and Underwood L.E. Uses of IGF-I in clinical conditions. J. Clin. Endocrinol. Metab. 79 (1994) 4-6
26. Conover C.A., Lee P.D.K., Kanaley J.A., Clarkson J.T., and Jensen M.D. Insulin regulation of insulin-like growth factor binding protein I in obese and nonobese humans. J. Clin. Endocrinol. Metab. 74 (1992) 1355-1360
27. Conover C.A., and Powell D.A. Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor downregulation and cell desensitization in cultured bovine fibroblasts. Endocrinology 129 (1991) 710-716
28. Cooke D.W., Bankert L.A., Roberts Jr. C.T., LeRoith D., and Casella S.J. Analysis of the human type I insulin-like growth factor receptor promoter region. Biochem. Biophys. Res. Commun. 177 (1991) 1113-1120
29. Daughaday W.H., and Rotwein P. Insulin-like growth factor I and II. Peptide messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endo. Rev. 10 (1989) 68-91
30. de Pagter-Holthuizen P., Jansen M., van der Kammen R.A., van Schaik F.M.A., and Sussenbach J.S. Differential expression of the human insulin-like growth factor II gene. Biochem. Biophys. Acta. 950 (1988) 282-295
31. de Pagter-Holthuizen P., Jansen M., van Schaik F.M.A., van der Kammen R.A., Oosterjk C., Van der Brande J.L., and Sussenbach J.S. The human insulin-like growth factor II contains two development-specific promoters. FEBS Lett. 214 (1987) 259-264
32. DeChiara T.M., Robertson E.J., and Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 64 (1991) 849-859
33. DeChiara T.M., Efstratiadis A., and Robertson E.J. A growth-deficiency phenotype in heterozygous mice carrying an insulin-like growth factor II gene disrupted by targeting. Nature (London) 345 (1991) 78-80
34. Delaney A.M., Pash J.M., and Canalis E. Cellular and clinical perspectives on skeletal IGF-I. J. Cell Biochem. 55 (1994) 328-333
35. Ding H., Kopple J.D., Cohen A., and Hirschberg R. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J. Clin. Invest. 91 5 (1993) 2281-2287
36. Dull T.J., Gray A., Hayflick J.S., and Ullrich A. Insulin-like growth factor II precursor gene organization in relation to the insulin gene family. Nature (London) 310 (1984) 777-781
37. Dunger D.B., Cheetham T.D., and Crowne E.C. Insulin-like growth factors (IGFs) and IGF-I treatment in the adolescent with insulin-dependent diabetes mellitus. Metabolism 44 10 Suppl 4 (1995) 119-123
38. Ebina Y., Ellis L., Jarnagin K., Edery M., Graf L., Clauser E., Qu J., Masiarz F., Kan Y.W., Goldfine I.D., Roth R.A., and Rutter W.J. The human insulin receptor cDNA: The structural basis for hormone-activated transmembrane signaling. Cell 40 (1985) 747-758
39. Elgin R.G., Busby W.H., and Clemmons D.R. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc. Natl. Acad. Sci. Acad. Sci. USA 84 (1987) 3245-3258
40. Fowlkes J., and Freemark M. Evidence for a novel insulin-like growth factor (IGF)-dependent protease regulating IGF-binding protein-4 in dermal fibroblasts. Endocrinology 131 (1992) 2071-2076
41. Frost R.A., and Tseng L. Insulin-like growth factor binding protein-1 is phosphorylated by cultured human endometrial stromal cells and multiple protein kinases in vitro. J. Biol. Chem. 266 (1991) 18082-18088
42. Gansler T., Furlanetto R., Stokes-Gramling T., Robinson K.A., Blocker N., Buse M.G., Sens D.A., and Garvin A.J. Antibody to type 1 insulin-like growth factor receptor inhibits growth of Wilms' tumor in culture and in athymic mice. Am. J. Pathol. 135 (1989) 961-966
43. Gelato M.C. GH-IGF-I and immune function. Trends in Endocrinol. Met. 4 (1993) 106-110
44. Giorgetti S., Ballotti R., Kowalski C.A., Tartare S., and Van Obberghen E. The insulin and insulin-like growth factor I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J. Biol. Chem. 268 (1993) 7358-7364
45. Gluckman P.D., Guan J., Bellharz E.J., Klempt N.D., Klempt M., Miller O., Sirimanne E., Dragunow M., and Williams C.E. The role of the insulin-like growth factor system in neuronal rescue. Ann. N.Y. Acad. Sci. 692 (1993) 138-148
46. Gronborg M., Wulff B.S., Rasmussen J.S., Kjeldsen T., and Gammeltoft S. Structure-function relationship of the insulin-like growth factor I receptor tyrosine kinase. J. Biol. Chem. 258 (1993) 23435-23440
47. moderator. Guler H.P. IGF-I treatment in noninsulin-dependent diabetes mellitus. In: Bondy C.A. (Ed). Clinical uses of IGF-I. Ann. Intern. Med. 120 (1994) 593-601
48. Guler H.P., Zapf J., and Froesch E.R. Short-term metabolic effects of recombinant human insulin-like growth factor in healthy adults. N. Engl. J. Med. 317 (1987) 137-140
49. Hall K., Johansson B.L., Povoa G., and Thalme B. Serum levels of insulin-like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion. J. Inter. Med. 225 (1989) 273-278
50. Halse J., Melsen F., and Mosekilde L. Iliac crest bone mass and remodeling in acromegaly. Acta Endocrinologica (Copenh) 97 (1981) 18-22
51. Han V.K., D'Ercole A.J., and Lund P.K. Cellular localization of somatomedin (insulin-like growth factor) mRNA in the human fetus. Science 286 (1987) 193-196
52. Hari J., Pierce S.B., Morgan D.O., Sara V., Smith M.C., and Roth R.A. The receptor for insulin-like growth factor II mediates an insulin-like response. EMBO J. 6 (1987) 3367-3371
53. Heppler J.E., Van Wyk J.J., and Lund P.K. Different half-lives of insulin-like growth factor mRNAs that differ in length of 3′-untranslated sequence. Endocrinology 127 (1990) 1550-1552
54. Hill D.J. Relative abundance and molecular size of IGFs in human fetal tissues. Early Human Fetal Dev. 21 (1990) 49-58
55. Holl R.W., Siegler B., Scherbaum W.A., and Heinze E. The serum GH binding protein is reduced in young patients with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 76 (1993) 165-167
56. Holthuizen P., van der Lee F.M., Ikejiri K., Yamamoto M., and Sussenbach J.S. Identification and initial characterization of a fourth leader exon and promoter of the human IGF-II gene. Biochem. Biophys. Acta 1087 (1990) 341-343
57. Hoyt E.C., Van Wyk J.J., and Lund P.K. Tissue and development-specific regulation of a complex family of rat insulin-like growth factor I messenger ribonucleic acids. Mol. Endocrinol. 2 (1988) 1077-1086
58. Irminger J.C., Rosen K.M., Humbel R.E., and Vila-Komaroff L. Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5′-untranslated regions. Biochemistry 84 (1987) 6330-6334
59. Ishii D.N. Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res. Brain Res. Rev. 20 1 (1995) 47-67
60. Ishii D.N., and Lupien S.B. Insulin-like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats. J. Neurosci. Res. 40 1 (1995) 138-144
61. Jansen E., Steenbergh P.H., LeRoith D., Roberts Jr. C.T., and Sussenbach J.S. Identification of multiple transcription start sites in the human IGF-I gene. Mol. Cell. Endocrinol. 78 (1991) 115-125
62. Jones J.L., and Clemmons D.R. Insulin-like growth factors and their binding proteins: Biological actions. Endo. Rev. 16 (1995) 3-34
63. Jones J.I., Gockerman A., Busby Jr. W.H., Wright G., and Clemmons D.R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the α5β1 integrin by means of its Arg-Gly-Asp sequence. Proc. Natl. Acad. Sci. USA 90 (1993) 10553-10557
64. Juul A., Bang P., Hertel N.T., Main K., Dalgaard P., Jorgensen K., Muller J., Hall K., and Skakkebaek N.E. Serum insulin-like growth factor I in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index. J. Clin. Endocrinol. Metab. 76 (1994) 744-752
65. Kappel C.C., Velez-Yanguas M.C., Hirschfeld S., and Helman L.J. Human osteosarcoma cell lines are dependent on IGF-I for in vitro growth. Cancer Res. 54 (1994) 2803-2807
66. Kato H., Faria T.N., Stannard B., Roberts Jr. C.T., and LeRoith D. Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor I (IGF-I) receptor. J. Biol. Chem. 265 (1993) 2655-2661
67. Kato H., Faria T.N., Stannard B., Roberts Jr. C.T., and LeRoith D. Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor I (IGF-I) receptor in IGF-I action. Mol. Endocrinol. 8 (1994) 40-50
68. Kikuchi K., Bichell D.P., and Rotwein P. Chromatin changes accompany the developmental activation of insulin-like growth factor I gene transcription. J. Biol. Chem. 267 (1992) 21505-21511
69. Kim S.-W., Lajara R., and Rotwein P. Structure and function of a human insulin-like growth factor I gene promoter. Mol. Endocrinol. 5 (1991) 1964-1972
70. Körner C., Nūrnberg B., Uhde M., and Braulke T. Mannose 6-phosphate/ insulin-like growth factor II receptor fails to interact with G-proteins. J. Biol. Chem. 270 (1995) 287-295
71. Kovacina K.S., and Roth R.A. Characterization of the endogenous insulin receptor-related receptor in neuroblastomas. J. Biol. Chem. 270 (1995) 1881-1887
72. Kupfer S., Underwood L., Baxter R., and Clemmons D. Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by the use of both agents simultaneously. J. Clin. Invest. 91 (1993) 383-390
73. Kuzuya H., Matsuura N., Sakamoto M., Makino H., Sakamoto Y., Kadowaki T., Suzuki Y., Kobayashi M., Akazawa Y., Nomura M., Yoshimasa Y., Kasuga M., Goji K., Nagataki S., Oyasu H., and Imura H. Trial of insulin-like growth factor I therapy for patients with extreme insulin resistance syndromes. Diabetes 42 (1993) 696-705
74. Lanes R., Recker B., Fort P., and Lifshitz F. Impaired somatomedin generation test in children with insulin-dependent diabetes mellitus. Diabetes 34 (1985) 156-160
75. Laron Z. Disorders of GH resistance in childhood. Curr. Opin. Pediatr. 5 (1993) 474-480
76. Laron Z., Anin S., Klipper-Auerbach Y., and Klinger B. Effects of insulin-like growth factor on linear growth, head circumference, and body fat in patients with Laron-type dwarfism. Lancet 339 (1992) 1258-1261
77. Lau M.M.H., Stewart C.E.H., Liu Z., Bhatt H., Rotwein P., and Stewart C.L. Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality. Genes & Development 8 (1994) 2953-2963
78. Leahy J.L., and Vandekerkhove K.M. Insulin-like growth factor I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology 126 (1990) 1593-1598
79. Leong S.R., Baxter R.C., Camerator T., Dai J., and Wood W.I. Structure and functional expression of acid labile subunit of the insulin-like growth factor binding protein complex. Mol. Endocrinol. 6 (1992) 870-876
80. LeRoith D., Baserga R., Helman L., and Roberts C.T. Insulin-like growth factors and cancer. Ann. Intern. Med. 122 (1995) 54-59
81. LeRoith D., Werner H., Beitner-Johnson D., and Roberts Jr. C.T. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endo. Rev. 16 (1995) 143-163
82. Lieberman S.A., Butterfield G.E., Harrison D., and Hoffman A.R. Anabolic effects of recombinant IGF-I in cachectic patients with acquired immunodeficiency syndrome. J. Clin. Endocrinol. Metab. 78 (1994) 400-410
83. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding IGF-I and the type I IGF receptor. Cell 75 (1993) 59-72
84. Liu J.-P., Baker J., Perkins A.S., Robertson E.J., and Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (IGF-1) and type 1 IGF receptor (Igflr). Cell 75 (1993) 73-82
85. Lobel P., Dalmas N.M., and Kornfeld S. Cloning and sequencing analysis of the cation-independent mannose-6-phosphate receptor. J. Biol. Chem. 263 (1988) 2563-2570
86. Lowe W.L. In: LeRoith D. (Ed). Insulin-like Growth Factors: Molecular and Cellular Aspects (1991), CRC Press 17-47
87. Lowe W.L., Roberts Jr. C.T., Lasky S.R., and LeRoith D. Differential expression of alternative 5′-untranslated regions in mRNAs encoding rat insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 84 (1987) 8946-8950
88. Lowe W.L., Lasky S.R., LeRoith D., and Roberts Jr. C.T. Distribution and regulation of rat insulin-like growth factor I messenger ribonucleic acids encoding alternative carboxy terminal E-peptides: Evidence for differential processing and regulation in liver. Mol. Endocrinol. 2 (1988) 528-535
89. Lund P.K., Moats-Staats B.M., Hynes M.A., Simmons J.G., Jansen M., D'Ercole A.J., and Van Wyk J.J. Somatomedin-C/insulin-like growth factor I and insulin-like growth factor II mRNAs in rat fetal and adult tissues. J. Biol. Chem. 261 (1986) 14539-14544
90. Lund P.K., Hoyt E.C., and Van Wyk J.J. The size heterogeneity of rat insulin-like growth factor I mRNAs is due primarily to differences in the length of 3′-untranslated sequence. Mol. Endocrinol. 3 (1989) 2054-2061
91. MacDonald R.G., Pfeffer S.R., Coussens L., Tepper M.A., Brocklebank C.M., Mole J.E., Andersen J.K., Chen E., Czech M.P., and Ullrich A. A single receptor binds both insulin-like growth factor II and mannose-6-phosphate. Science 239 (1988) 3334-3357
92. Mamula P.W., and Goldfine I.D. Cloning and characterization of the human insulin-like growth factor I receptor gene 5′-flanking region. DNA Cell Biol. 11 (1992) 43-50
93. Mann D.R., Rudman C.G., Akinbami M.A., and Gould K.G. Preservation of bone mass in hypogonadal female monkeys with recombinant human growth hormone administration. J. Clin. Endocrinol. Metab. 74 (1992) 1263-1269
94. Matsmaga H., Nishimoto L., Kojima L., Yamashita N., Knrokawa K., and Ogata E. Activation of a calcium-permeable cation channel by insulin-like growth factor II in BALB/c 3T3 cells. Am. J. Physiol. 255 (1988) C442-C446
95. Mauras N., Horber F.F., and Haymond M.W. Low dose recombinant IGF-I fails to affect protein anabolism but alters islet cell secretion in humans. J. Clin. Endocrinol. Metab. 75 (1992) 1192-1197
96. Miller S.B., Martin D.R., Kissane J., and Hammerman M.R. Rat models for clinical use of insulin-like growth factor I in acute renal failure. Am. J. Physiol. 266 (1994) F949-F956
97. Morgan D.O., Edman J.C., Standring D.N., Fried V.A., Smith M.C., Roth R.A., and Rutter W.J. Insulin-like growth factor II receptor as a multifunctional binding protein. Nature (London) 329 (1987) 301-307
98. (Abst.). Morrow L., O'Brien M., Moller D., Flier J., and Moses A. Recombinant human IGF-I reverses hyperglycemia and improves insulin sensitivity in severe insulin resistance. Diabetes 42 (1993) 269
99. Moses A.C., Young S.C., Morrow L.A., O'Brien M., and Clemmons D.R. Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 45 1 (1996) 91-100
100. Myers Jr. M.G., Backer J.M., Sun X.J., Shoelson S., Hu P., Schlessinger J., Yoakim M., Schaffhausen B., and White M.F. IRS-1 activates phosphatidylinositol 3′-kinase by associating with src homology 2 domans of p85. Proc. Natl. Acad. Sci. USA 89 (1992) 10350-10354
101. Myers M.G.J., Sun X.J., Cheatham B., Jachna B.R., Glasheen E.M., Backer J.M., and White M.F. IRS-1 is a common element in insulin and insulin-like growth factor I signaling to the phosphatidylinositol 3′-kinase. Endocrinology 132 (1993) 1421-1430
102. Myers Jr. M.G., and White M.F. The new elements of insulin signaling: Insulin receptor substrate-1 and proteins with SH2 domains. Diabetes 42 (1993) 643-650
103. Nam T.J., Busby Jr. W.H., and Clemmons D.R. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor binding protein-5. Endocrinology 135 (1994) 1385-1391
104. Nishimoto L., Ogata E., and Kojima I. Pertussis toxin inhibits the action of insulin-like growth factor I. Biochem. Biophys. Res. Commun. 148 (1987) 403-441
105. Nishimoto L., Murayama Y., Katada T., Ui M., and Ogata E. Possible direct linkage of insulin-like growth factor II receptor with guanine nucleotide-binding proteins. J. Biol. Chem. 264 (1989) 14029-14038
106. Okamoto T., Katada T., Murayama Y., Ui M., Ogata E., and Nishimoto I. A simple structure encodes G protein-activating function of the IGF-II/mannose-6-phosphate receptor. Cell 62 (1990) 709-717
107. O'Shea M.H., Miller S.F., and Hammerman M.R. Effects of IGF-I on renal function in patients with chronic renal failure. Am. J. Physiol. 264 (1993) F917-F922
108. Pedone P.V., Cosma M.P., Ungaro P., Colantuonis V., Bruni C.B., Zarrilli R., and Riccio A. Parental imprinting of rat insulin-like growth factor Il gene promoters is coordinately regulated. J. Biol. Chem. 269 (1994) 23970-23975
109. Phillips L.S., Goldstein S., and Pao C.L. Nutrition and somatomedin. XXVI. Molecular regulation of IGF-I by insulin in cultured rat hepatocytes. Diabetes 40 (1991) 1525-1530
110. Powell-Braxton L., Hollingshead P., Warburton C., Dowd M., Pitts-Meek S., Dalton D., Gillett N., and Stewart T.A. IGF-I is required for normal embryonic development in mice. Genes Dev. 7 (1993) 2609-2617
111. Press M., Tamborlane W.V., and Sherwin R.S. Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes. N. Engl. J. Med. 310 (1984) 810-815
112. Quin J.D., Fisher B.M., Paterson K.R., Inoue A., Beastall G.H., and MacCuish A.C. Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome [letter]. N. Engl. J. Med. 323 (1990) 425-426
113. Rabkin R. Insulin-like growth factor-I treatment of acute renal failure. J. Lab. Clin. Med. 125 6 (1995) 684-685
114. Rechler M.M., and Nissley S.P. In: Sporn N.H., and Roberts A.B. (Eds). Peptide Growth Factors and Their Receptors (1990), Springer-Verlag, Boca Raton, FL 263-282
115. Rechler M.M. In: LeRoith D. (Ed). Insulin-like Growth Factors: Molecular and Cellular Aspects (1991), CRC Press, Berlin 87-110
116. Rechler M.M. Insulin-like growth factor binding proteins. Vitam. Horm. 47 (1993) 1-114
117. Reinhardt R.R., Chin E., Zhang B., Roth R.A., and Bondy C.A. Insulin receptor-related receptor messenger ribonucleic acid is focally expressed in sympathetic and sensory neurons and renal distal tubule cells. Endocrinology 133 (1993) 3-10
118. Rennert N.J., Caprio S., and Sherwin R.S. Insulin-like growth factor I inhibits glucose-stimulated insulin secretion, but does not impair glucose metabolism in normal humans. J. Clin. Endocrinol. Metab. 76 (1993) 804-806
119. Roback E.W., Barakat A.J., Mibikay M., Chretien M., and Butler M.G. An infant with deletion of the distal long arm of chromosome 15 (q26.1) and loss of IGF-I receptor gene. Am. J. Med. Genet. 38 (1991) 74-79
120. Rogers S.A., and Hammerman M.R. Insulin-like growth factor II stimulates production of inositol triphosphate in proximal tubular basolateral membranes from canine kidney. Proc. Natl. Acad. Sci. USA 85 (1988) 4037-4041
121. Rogler C.E., Yang D., Rossetti L., Donohoe J., Alt E., Chang C.J., Rosenfeld R., Neely K., and Hintz R. Altered body composition and increased frequency of diverse malignancies in IGF-II transgenic mice. J. Biol. Chem. 269 (1994) 13779-13784
122. Rotwein P.S., Pollock K.M., Didier D.K., and Krivi G.G. Organization and sequence of the human insulin-like growth factor I gene. J. Biol. Chem. 261 (1986) 4828-4832
123. Schoenie E.J., Zenobi P.D., Torresani T., Werder E.A., Zachmann M., and Froesch E.R. Recombinant human insulin-like growth factor I (rhIGF-I) reduces hyperglycaemia in patients with extreme insulin resistance. Diabetologia 34 (1991) 675-679
124. Shapiro D.N., Jones B.G., Shapiro L.H., Dias P., and Houghton P.J. Antisense-mediated reduction in insulin-like growth factor I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Invest. 94 (1994) 1235-1242
125. Shimatsu A., and Rotwein P. Mosaic evolution of the insulin-like growth factors: Organization, sequence, and expression of the rat insulin-like growth factor I gene. J. Biol. Chem. 262 (1987) 7894-7900
126. Shimatsu A., and Rotwein P. Sequence of two rat insulin-like growth factor I mRNAs differing within the 5′-untranslated region. Nucleic Acids Res. 15 (1987) 7196-7204
127. Sinha M., Buchanan C., Leggett N., Martin L., Khazanie P.G., Dimarchi R., Pories W.J., and Caro J. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport. Diabetes 38 (1989) 1217-1225
128. moderator. Skarulis M. IGF-I treatment in extreme insulin resistance. In: Bondy C.A. (Ed). Clinical uses of IGF-I. Ann. Intern. Med. 120 (1994) 593-601
129. Skolnik E.Y., Batzer A., Li N., Lee C.-H., Lowenstein E., Mohammadi M., and Schlessinger J. The function of GRB2 in linking the insulin receptor to ras signaling pathways. Science 260 (1993) 1953-1955
130. Smale S.T., and Baltimore D. The "initiator" as a transcription control element. Cell 57 (1989) 103-113
131. Steenbergh P.H., Koonen-Reemst A.M.C.B., Clentjens C.B.J.M., and Sussenbach J.S. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem. Biophys. Res. Commun. 175 (1991) 507-514
132. Steenman M.J.C., Rainier S., Dobry C.J., Grundy P., Horon I.L., and Feinberg A.P. Loss of imprinting of IGF2 is linked to reduced expression and abnormal methylation of H19 in Wilms' tumor. Nature Genetics 7 (1994) 433-440
133. Stylianopoulou F., Efstratiadis A., Herbert J., and Pintar J. Pattern of insulin-like growth factor II gene expression during rat embryogenesis. Development 103 (1988) 497-506
134. Suikkari A.-M., Kovisto V.A., Rutanen E.-M., Yki-Jarvinen H., Karonen S.-L., and Seppala M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J. Clin. Endocrinol. Metab. 66 (1988) 266-272
135. Sun X.J., Rothenberg P., Kahn C.R., Backer J.M., Araki E., Wilden P.A., Cahill D.A., Goldstein B.J., and White M.F. The structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 352 (1991) 73-77
136. Sussenbach J.S. The gene structure of the insulin-like growth factor family. Prog. Growth Factor Res. 1 (1989) 33-48
137. Sussenbach J.S., Rodenburg R.J.T., Scheper W., and Holthuizen P. In: LeRoith D., and Raizada M.K. (Eds). Current Directions in Insulin-like Growth Factor Research (1994), Plenum Press, Boca Raton FL 63-71
138. Tricoli J.V., Rall L.B., Scott J., Bell G.I., and Shows T.B. Localization of insulin-like growth factor genes to human chromosomes 11 and 12. Nature (London) 310 (1984) 784-786
139. Ullrich A., Gray A., Tam A.W., Yang-Feng T., Tsubowka M., Collins C., Henzel W., LeBon T., Kathuria S., Chen F., Jacobs S., Francke U., Ramachandran J., and Fujita-Yamaguchi Y. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests determinants that define functional specificity. EMBO J. 5 (1986) 2503-2512
140. Ullrich A., Bell J.R., Chen E.Y., Herrera R., Petruzzeli L.M., Dull T.J., Gray A., Coussens L., Liao Y.-C., Tsubokawa M., Mason A., Seeburg P.H., Grunfeld C., Rosen O.M., and Ramachandran J. Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes. Nature 313 (1985) 756-761
141. Usala A.L., Madigan T., Burguera B., Sinha M.K., Caro J.F., Cunningham P., Powell J.G., and Butler P.C. Brief report: Treatment of insulin-resistant diabetic ketoacidosis with insulin-like growth factor I in an adolescent with insulin-dependent diabetes. N. Engl. J. Med. 327 (1992) 853-857
142. Vu T.H., and Hoffman A.R. Promoter-specific imprinting of the human insulin-like growth factor II gene. Nature 371 (1994) 714-717
143. Walker J., Van Wyk J.J., and Underwood L. Stimulation of statural growth by recombinant insulin-like growth factor I in a child with growth hormone insensitivity syndrome (Laron-type). J. Pediatr. 121 (1992) 641-646
144. Wang Z.-Q., Fung M.R., Barlow D.P., and Wagner E.F. Regulation of embryonic growth and lysosomal targeting by the imprinted Igf2/Mpr gene. Nature 372 (1994) 464-466
145. Weksberg R., Shen D.R., Fei Y.L., Song Q.L., and Squire J. Disruption of IGF-2 imprinting in Beckwith-Wiedmann syndrome. Nature Genetics 5 (1994) 143-149
146. Werner H., Raizada M., Mudd L., Foyt H., Simpson I., Roberts C.T., and LeRoith D. Regulation of rat brain/HepG2 glucose transporter gene expression by insulin and insulin-like growth factor I in primary cultures of neuronal and glial cells. Endocrinology 125 (1989) 314-319
147. Werner H., Woloschak M., Adamo M., Shen-Orr Z., Roberts Jr. C.T., and LeRoith D. Developmental regulation of the rat insulin-like growth factor I receptor gene. Proc. Natl. Acad. Sci. USA 86 (1989) 7451-7455
148. Werner H., Stannard B., Bach M.A., LeRoith D., and Roberts Jr. C.T. Cloning and characterization of the proximal promoter region of the rat insulin-like growth factor I (IGF-I) receptor gene. Biochem. Biophys. Res. Commun. 169 (1990) 1021-1027
149. Werner H., Bach M.A., Stannard B., Roberts Jr. C.T., and LeRoith D. Structural and functional analysis of the insulin-like growth factor I receptor gene promoter. Mol. Endocrinol. 6 (1992) 1545-1558
150. Werner H., Adamo M., Roberts Jr. C.T., and LeRoith D. Molecular and cellular aspects of insulin-like growth factor action. Vitam. Horm. 48 (1994) 1-58
151. in press. Werner H., and LeRoith D. In: Klein G., and Van de Woude G.F. (Eds). Advances in Cancer Research (1995), Academic Press, Inc., New York
152. Wood W.I., Cachianes G., Henzel W.J., Winslow G.A., Spencer S.A., Hellmiss R., Martin J.L., and Baxter R.C. Cloning and expression of the GH dependent insulin-like growth factor binding protein. Mol. Endocrinol. 2 (1988) 1176-1185
153. Yamamoto K., Lapetina E.G., and Moxham C.P. Insulin-like growth factor-I induces limited association of phosphatidylinositol 3-kinase to its receptor. Endocrinology 130 (1992) 1490-1498
154. Yao D.L., Liu X., Hudson L.D., and Webster H.D. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 92 (1995) 6190-6194 13
155. Zenobi P.D., Jaeggi-Groisman S.E., Riesen W.F., Roder M., and Froesch E.R. Insulin-like growth factor I improves glucose and lipid metabolism in type 2 diabetes mellitus. J. Clin. Invest. 90 (1992) 2234-2241
156. Zhan S., Shapiro D.N., and Helman L.J. Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma. J. Clin. Invest. 94 (1994) 445-448
157. Zhang B., and Roth R.A. The insulin receptor-related: Tissue expression, ligand binding specificity, and signaling capability. J. Biol. Chem. 267 (1992) 18320-18328
158. Zhou J., and Bondy C.A. IGF-II and its binding proteins in the placenta. Endocrinology 131 (1992) 1230-1240